Austar Hearing Science & Technology (Xiamen) Co., Ltd men) Co., Ltd.

Austar Hearing Science & Technology (Xiamen) Co., Ltd. specialises in air-conduction hearing aids, which are devices designed to amplify sound for individuals with hearing loss. Their portfolio includes three primary form factors: behind-the-ear (BTE), in-the-ear (ITE), and receiver-in-the-ear (RITE) models. These devices are tailored to address mild to severe hearing impairments by delivering customised amplification solutions.

The company is based in the United States. This location is relevant for regulatory oversight and compliance, as it aligns with the FDA’s jurisdiction over medical devices marketed in the US.

Austar’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is a global standard for identifying medical devices, ensuring traceability and transparency in regulatory tracking. This listing helps healthcare providers and regulators verify the identity and classification of their hearing aids.

Austar’s hearing aids fall into two regulatory classes: Class I and Class II. Class I devices generally pose minimal risk and may require less stringent regulatory controls, while Class II devices involve a higher level of risk and require premarket notification (510(k)) or other regulatory submissions to demonstrate safety and effectiveness. The classification depends on factors like the device’s intended use, potential risks, and design complexity.